N-(1-(Hydroxymethyl)propyl)-1-methyl-dextro-(+)-lysergamide
Brand names,
N-(1-(Hydroxymethyl)propyl)-1-methyl-dextro-(+)-lysergamide
Analogs
N-(1-(Hydroxymethyl)propyl)-1-methyl-dextro-(+)-lysergamide
Brand Names Mixture
N-(1-(Hydroxymethyl)propyl)-1-methyl-dextro-(+)-lysergamide
Chemical_Formula
C21H27N3O2
N-(1-(Hydroxymethyl)propyl)-1-methyl-dextro-(+)-lysergamide
RX_link
http://www.rxlist.com/cgi/generic3/sansert.htm
N-(1-(Hydroxymethyl)propyl)-1-methyl-dextro-(+)-lysergamide
fda sheet
N-(1-(Hydroxymethyl)propyl)-1-methyl-dextro-(+)-lysergamide
msds (material safety sheet)
N-(1-(Hydroxymethyl)propyl)-1-methyl-dextro-(+)-lysergamide
Synthesis Reference
No information avaliable
N-(1-(Hydroxymethyl)propyl)-1-methyl-dextro-(+)-lysergamide
Molecular Weight
353.458 g/mol
N-(1-(Hydroxymethyl)propyl)-1-methyl-dextro-(+)-lysergamide
Melting Point
195 oC
N-(1-(Hydroxymethyl)propyl)-1-methyl-dextro-(+)-lysergamide
H2O Solubility
No information avaliable
N-(1-(Hydroxymethyl)propyl)-1-methyl-dextro-(+)-lysergamide
State
Solid
N-(1-(Hydroxymethyl)propyl)-1-methyl-dextro-(+)-lysergamide
LogP
1.55
N-(1-(Hydroxymethyl)propyl)-1-methyl-dextro-(+)-lysergamide
Dosage Forms
Tablet
N-(1-(Hydroxymethyl)propyl)-1-methyl-dextro-(+)-lysergamide
Indication
For the treatment of vascular headache
N-(1-(Hydroxymethyl)propyl)-1-methyl-dextro-(+)-lysergamide
Pharmacology
Methysergide has been shown, in vitro and in vivo, to inhibit or block the effects of serotonin, a substance which may be involved in the mechanism of vascular headaches. Serotonin has been variously described as a central neurohumoral agent or chemical mediator, as a "headache substance" acting directly or indirectly to lower pain threshold, as an intrinsic "motor hormone" of the gastrointestinal tract, and as a "hormone" involved in connective tissue reparative processes.
N-(1-(Hydroxymethyl)propyl)-1-methyl-dextro-(+)-lysergamide
Absorption
Rapid
N-(1-(Hydroxymethyl)propyl)-1-methyl-dextro-(+)-lysergamide
side effects and Toxicity
No information avaliable
N-(1-(Hydroxymethyl)propyl)-1-methyl-dextro-(+)-lysergamide
Patient Information
No information avaliable
N-(1-(Hydroxymethyl)propyl)-1-methyl-dextro-(+)-lysergamide
Organisms Affected
Humans and other mammals